News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
Participant advisory group at RECOVER hub raises awareness about Long COVID
The ILLInet PARATROOPers, a a group of RECOVER study participants, collaborate with researchers to center the voices of Long COVID patients, improve RECOVER studies, and raise awareness about the condition.
Feature
46 Results
46 Results
First results from RECOVER-AUTONOMIC clinical trials to be shared at upcoming conference
Results from the RECOVER-AUTONOMIC Moderate POTS (Ivabradine) clinical trial will be presented at an upcoming session of the American College of Cardiology (ACC) Annual Conference on March 28, 2026.
Announcement
RECOVER-TLC seeks input on planned study of possible Long COVID treatment
A public comment period will allow patients, caregivers, and researchers to comment on a study to test whether stellate ganglion nerve block (SGB) can help improve Long COVID symptoms.
Announcement
5 years in, RECOVER continues to advance its patient-centered mission
RECOVER marks 5 years of Long COVID research, with NIH leaders, scientists, and clinicians continuing to guide and advance the initiative’s mission. In 2026, RECOVER will expand clinical trials to find answers for the Long COVID community.
News Release
RECOVER-SLEEP enrollment process prioritized overall health of potential participants
While recruiting potential participants for its clinical trials focused on sleep disturbances, RECOVER study teams also conducted additional health screenings to identify and treat individuals with a sleep condition called sleep apnea.
Feature
A year of discovery: Looking back at 2025 and ahead to 2026
In 2025, RECOVER’s progress included closing the first phase of its adult observational study and publishing its first clinical trial results. This year, the initiative continues its studies and sharing research findings.
Feature
RECOVER-TLC to hold next webinar January 23, 2026
On January 23, NIH and FNIH leaders will hold a RECOVER-TLC webinar to provide updates and answer questions about RECOVER’s latest clinical trial efforts.
Announcement
RECOVER-ENERGIZE clinical trials achieve early enrollment: How collaboration and communication drove success
A network of 42 RECOVER sites across the US worked to reach out to potential study participants, communicate with the trial team, and reach the trials’ enrollment goal 2 months ahead of schedule.
Feature
RECOVER-TLC invites public comments on upcoming clinical trials
Feedback from patients, caregivers, and others will help shape studies testing the safety and effectiveness of potential Long COVID treatments.
Announcement